Trials / Completed
CompletedNCT05304299
Alleviating Effects Against High Intraocular Pressure by Oral Intake of Cordyceps Cicadae Mycelia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Han-Hsin Chang · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate the effects of lowering intraocular pressure by oral intake of Cordyceps cicadae mycelia, to provide evidence-based data for high intraocular pressure relief.
Detailed description
Study purpose This study investigated the effeicacy of oral Cordyceps cicadae mycelia for the relief of high intraocular pressure. Subjects 1. The total recruitment of subjects is 60 people, aged between 20 to 75 years. 2. Subjects with intraocular pressure more than or equal to 21 mmHg are included, irrespective of whether on us of Taflotan (saflutan). Methods 1\. Informed consents will be obtained from subjects first. The subjects with pre-test intraocular pressure over or equal 21 mm Hg are advised to orally take two capsules containing a total of 500 mg of Cordyceps cicadae mycelia. After 90 minutes, the subjects are evaluated for intraocular pressure. The pre-test and and post-intake intraocualr pressure and blood pressure data will be compared by paired t test for significant differences if any.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Cordyceps Cicadae Mycelia | Cordyceps Cicadae Mycelia will be given to test its potential for alleviation of high intraocular pressure. |
Timeline
- Start date
- 2020-03-10
- Primary completion
- 2021-07-31
- Completion
- 2021-12-31
- First posted
- 2022-03-31
- Last updated
- 2022-03-31
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05304299. Inclusion in this directory is not an endorsement.